Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Activity and tolerance of XL647 in NSCLC patients with acquired resistance to EGFR-TKIs: Preliminary results of a phase II trial Miller, V. A., Wakelee, H. A., Lara, P. N., Cho, J., Chowhan, N. M., Costa, D., Vrindavanam, N., Yanagihara, R., Pennell, N., Lynch, T. J. AMER SOC CLINICAL ONCOLOGY. 2008
View details for DOI 10.1200/jco.2008.26.15_suppl.8028
View details for Web of Science ID 000208457402801